[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343565-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343565-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","endoscopic-screening-for-identification-of-signet-ring-cell-gastric-cancer-foci-in-carriers-of-germline-pathogenic-variants-in-cdh1","Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1","","Preoperative detection of signet ring cancer cells (SRC) on upper endoscopy is evaluated in patients with CDH1 pathogenic variants (PV) undergoing gastrectomy. The study also assesses whether surveillance supports development of advanced diffuse gastric cancer in patients who choose endoscopic follow-up. Forty-eight asymptomatic CDH1 PV carriers with at least one surveillance EGD were analyzed for SRC yield on surgery specimens and subsequent progression during annual endoscopy, including an assessment of surgical stage and longitudinal outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/endoscopic-screening-for-identification-of-signet-ring-cell-gastric-cancer-foci-in-carriers-of-germline-pathogenic-variants-in-cdh1/343565/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/endoscopic-screening-for-identification-of-signet-ring-cell-gastric-cancer-foci-in-carriers-of-germline-pathogenic-variants-in-cdh1/343565.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary goal of this study?","Question",{"text":63,"@type":64},"Determine the preoperative detection of signet ring cancer cells (SRC) on upper endoscopy in CDH1 PV carriers undergoing gastrectomy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients selected for analysis?",{"text":68,"@type":64},"Consecutive asymptomatic CDH1 PV carriers aged 13–90 were retrospectively identified, and those with at least one EGD for surveillance between 2007 and 2022 were included.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings from gastrectomy specimens and endoscopy detection?",{"text":72,"@type":64},"SRC was found on gastrectomy specimens in 21 of 24 patients (87.5%). Among those, EGD identified SRC in 17 of 21 patients (sensitivity 81%), and cancers were stage pT1a.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343565,1790379107,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Familial Cancer (2024) 23:617–626  \n[https://doi.org/10.1007/s10689-024-00421-z](https://doi.org/10.1007/s10689-024-00421-z)  \nRESEARCH ARTICLE  \nEndoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1  \nLady Katherine Mejia Perez1 · Margaret O’Malley2,3 · Arjun Chatterjee4 · Ruishen Lyu5 · Qijun Yang5 ·  \nMichael W. Cruise3,6 · Lisa LaGuardia2,3 · David Liska2,3 · Carole Macaron1,3 · R. Matthew Walsh3,7 · Carol A. Burke1,2,3  \nReceived: 2 June 2024 / Accepted: 3 September 2024 / Published online: 11 September 2024 © The Author(s) 2024  \nAbstract  \nTo determine the preoperative detection of signet ring cancer cells (SRC) on upper endoscopy (EGD) in patients with CDH1 pathogenic variant (PV) undergoing gastrectomy. To evaluate the development of advanced diffuse gastric cancer (DGC) in patients choosing surveillance. Guidelines recommend prophylactic total gastrectomy (pTG) in CDH1 PV carriers with family history of DGC between 18 and 40 years. Annual EGD with biopsies according to established protocols is recommended in carriers with no SRC and no family history of DGC, with consideration of pTG. Retrospective analysis of asymptomatic patients with CDH1 PVs with ≥ 1 surveillance EGD. Outcomes included pre-operative EGD detection of SRC, surgical stage, and progression to advanced DGC in those electing surveillance with EGD. 48 patients with CDH1 PVs who had ≥ 1 EGD were included. 24/ 48 (50%) underwent gastrectomy, including pTG in 7 patients. SRCC were detected on gastrectomy specimen in 21/24 (87.5%) . SRCs were identified by EGD in 17/21 patients who had SRCC on gastrectomy specimens (sensitivity 81%, 17/21) . All cancers were stage pT1a. The remaining 17 patients (50% with a family history of gastric cancer) continue in annual EGD surveillance with a median follow-up of 34.6 months. No SRCC or advanced DGC have been diagnosed. No CDH1 PV carriers without SRCC on random biopsies followed in an endoscopic program developed advanced DGC over a median follow up of 3 years. In the short term, EGD surveillance might be a safe alternative to immediate pTG in experienced hands in referral centers.  \nKeywords Hereditary diffuse gastric cancer · Endoscopy · Surveillance · Gastrectomy · CDH1  \n􀀍 CarolA. Burke [burkec1@ccf.org](burkec1@ccf.org)  \n1 Department of Gastroenterology, Hepatology and Nutrition Digestive Disease and Surgical Institute, Cleveland Clinic, DeskA30, 9500 Euclid Avenue, Cleveland, OH 44195, USA  \n2 Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA  \n3 Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, OH, USA  \n4 Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA  \n5 Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA  \n6 Department of Pathology and Lab Medicine, Cleveland Clinic, Cleveland, OH, USA  \n7 Department of General Surgery, Cleveland Clinic, Cleveland, OH, USA  \nBackground  \nCDH1 pathogenic variants (PVs) are responsible for 40% of cases of hereditary diffuse gastric cancer (HDGC), which isan autosomal dominant syndrome with variable penetrance. The reported cumulative risk of DGC by age 80 years in carriers of CDH1 PVs is reported to be 33 to 42%, and more recent data suggest that the risk is as low as 7–10%[1–3]. That data is discrepant with prophylactic gastrectomy (pTG) specimens demonstrating up to 97% of asymptomatic PV carriers have early-stage DGC regardless of preoperative detection of SRC [4–12] . Updated guidelines for the management of patients with CDH1 PVs recommend prophylactic total gastrectomy (pTG) in early adulthood for CDH1 PV carriers with a family history of DGC regardless of the presence of SRC on endoscopic biopsy while total gastrectomy (TG) is recommended in those with SRC detected on EGD [13] . Upper endoscopy (EGD) surveillance is recommended annually in patients without SRC or  \na family his","cbCaiiPI5JUjCfgx","https://ap.wps.com/l/cbCaiiPI5JUjCfgx","pdf",1337272,"English","# Abstract\n# Background\n# Methods\n## Study design","[{\"question\":\"What is the primary goal of this study?\",\"answer\":\"Determine the preoperative detection of signet ring cancer cells (SRC) on upper endoscopy in CDH1 PV carriers undergoing gastrectomy.\"},{\"question\":\"How were patients selected for analysis?\",\"answer\":\"Consecutive asymptomatic CDH1 PV carriers aged 13–90 were retrospectively identified, and those with at least one EGD for surveillance between 2007 and 2022 were included.\"},{\"question\":\"What were the key findings from gastrectomy specimens and endoscopy detection?\",\"answer\":\"SRC was found on gastrectomy specimens in 21 of 24 patients (87.5%). Among those, EGD identified SRC in 17 of 21 patients (sensitivity 81%), and cancers were stage pT1a.\"}]","Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1 | PDF",1790051443,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ccd324b2016e38e59e0bd751f6cd3b16.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe3b5d2f87bb3e219150667888050580.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d380df5bcea610b5c9d9ed302a66278a.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55021a9ba8cef6ef9f7088ff36674864.webp",980,1301]